PROVIDER PROFILE · NPI 1588635312

Shahid MalikMD

PRACTICETHE ONCOLOGY INSTITUTE CA, A PROFESSIONAL CORPORATIONSee all providers at this practice →

Hematology-OncologyLas Vegas, NVI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,041

Unique beneficiaries

—

Total services

5,706

Distinct HCPCS

Medicare payment

$138K

Peer benchmark

Total Medicare services vs. 54 Hematology-Oncology providers in NV — below median (cohort median 126,412).

PRESCRIBING · PART D · 2024

Total Rx claims

235

Beneficiaries

—

Total drug cost

$1.1M

Distinct drugs

Brand share

56.2%

Top prescribed drugs

Ruxolitinib Phosphate57 claims

Apixaban40 claims

Hydroxyurea30 claims

Letrozole23 claims

Prednisone19 claims

QUALITY · MIPS · 2024

Final MIPS score

0.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

-9.00%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

Education$186

Top paying entities

Food and Beverage$2K

Education$186

REFERRAL NETWORK

Where Shahid Malik's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Quest Diagnostics Incorporated Clinical Laboratory · Las Vegas, NV	87	1,585
Carlos Araujo Hematology-Oncology · Las Vegas, NV	14	370

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history